NCT03741361

Brief Summary

120 consecutive female patients, 18-65 years old, American Society of Anesthesiologists (ASA) physical status I to II, scheduled for hysteroscopic surgery under propofol-based intravenous anesthesia will be recruited in this cohort study. The day before surgery, participants will be assessed the state of preoperative anxiety and depression. On the day of surgery, propofol will be administered by target controlled infusion (TCI) pump. During induction of anesthesia, the level of sedation will be evaluated. The induction dose of propofol, target effect-site concentration(Cet), plasma concentration(Cp) and effect-site concentration (Ce) of propofol will be recorded.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 11, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 14, 2018

Completed
13 days until next milestone

Study Start

First participant enrolled

November 27, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2019

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2019

Completed
Last Updated

July 9, 2019

Status Verified

July 1, 2019

Enrollment Period

2 months

First QC Date

November 11, 2018

Last Update Submit

July 7, 2019

Conditions

Keywords

FemaleProspective StudiesAnesthetics, IntravenousPropofolAnxiety/*psychologyDepression/*psychology

Outcome Measures

Primary Outcomes (1)

  • Effect-site concentration (Ce) of propofol

    Effect-site concentration (Ce) of propofol on the TCI-system at the sedative level of OAA/S score of 3, OAA/S score of 1, and OAA/S core of 1 and NI\<64 reached will be recorded.

    Time of induction is less than 10 minutes.

Secondary Outcomes (1)

  • The induction dose of propofol

    Time of induction is less than 10 minutes.

Study Arms (1)

Anxiety and Depression

Female patients scheduled for hysteroscopic surgery under propofol-based intravenous anesthesia will be recruited in this prospective cohort study.

Other: anxiety and depression

Interventions

Female patients who have a previous history of surgery or infertility, or a history of miscarriage or abortion are often susceptible to preoperative anxiety or depression. We will observe the effect of anxiety and depression on the dosage of propofol during induction.

Anxiety and Depression

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Female patients, 18-65 years old, American Society of Anesthesiologists (ASA) physical status I or II, scheduled for hysteroscopic surgery under propofol-based intravenous anesthesia in the first affiliated hospital of Sun Yat-sen University in Guangzhou, China will be recruited in this cohort study.

You may qualify if:

  • female
  • American Society of Anesthesiologists(ASA) physical status I or II
  • Body Mass Index(BMI) 18-25kg/m2
  • scheduled for hysteroscopic surgery under propofol-based intravenous anesthesia.

You may not qualify if:

  • suffering from psychiatric diseases.
  • chronic use of anxiolytics, antidepressants, and sedative-hypnotics.
  • any sedative premedication.
  • a history of alcohol abuse.
  • allergy to propofol.
  • declining to participate and cooperate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, 510000, China

Location

Related Publications (1)

  • Li RY, Lin M, Jiang HY, Wen SH, Shen JT, Huang WQ, Zhang XY. Impact of Anxiety or Depression Symptoms on Propofol Requirements for Sedation in Females: A Prospective Cohort Study. J Clin Pharmacol. 2020 Oct;60(10):1376-1384. doi: 10.1002/jcph.1631. Epub 2020 May 23.

Biospecimen

Retention: SAMPLES WITHOUT DNA

An intravenous cannula was placed and 5 ml blood sample was drawn from each patient. The serum was separated and immediately stored at -80℃ for later analysis.

MeSH Terms

Conditions

Anxiety DisordersDepression

Interventions

Patient Health Questionnaire

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Surveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesPsychological TestsBehavioral Disciplines and ActivitiesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Xuyu Zhang, M.D. and Ph.D

    Department of Anesthesiology,The first affiliated hospital of Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 11, 2018

First Posted

November 14, 2018

Study Start

November 27, 2018

Primary Completion

February 1, 2019

Study Completion

February 15, 2019

Last Updated

July 9, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication will be shared.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Starting 6 months after publication.

Locations